🇺🇸 FDA
Patent

US 8551536

Nitrite and nitrite-metheme therapy to detoxify stroma-free hemoglobin based blood substitutes

granted A61KA61K31/555A61K33/00

Quick answer

US patent 8551536 (Nitrite and nitrite-metheme therapy to detoxify stroma-free hemoglobin based blood substitutes) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Oct 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Oct 08 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/555, A61K33/00, A61K33/26, A61P